Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results March 24, 2026
Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the ‘industry is hungriest for’ March 19, 2026
Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting March 18, 2026
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces March 18, 2026
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights March 6, 2026
